Recently visited unit

Optional shares

name	Price (yuan)	Rise and fall
The following are popular stocks

Please check the self selected shares first Sign in

name	Price (yuan)	Rise and fall

Management of self selected shares

^_^ sign out

join remind View in APP

ST eye drug (600671.SH)

Questioning stocks

@change@

@changeP@

@now@

Limit: @ up_limit@

Limit: @ down_limit@

Suspension

@date@ @time@

Temporary suspension

Today:	@open@	Volume:	@volume@	Amplitude:	@swing@
Maximum:	@high@	Turnover:	@amount@	turnover rate:	@turnover@
Minimum:	@low@	Total Market Value:	@fixTotalShare@	P/B ratio:	@pb@
Received yesterday:	@preClose@	Circulation value:	@cvs@	P/E ratio^TTM ：	@pe@
Total share capital:	@zgb@	Circulating shares:	@ltgb@

Information mine:

The browser version is too low to view the multi null inversion

Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Time-sharing

Day K

Week K

Month K

K line

Reinstatement K line

Technical drawings

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Also concerned:

5th gear disc opening

Live broadcast of famous teachers

Commission ratio -- Abandonment --
Selling ⑤	--	--
Sell ④	--	--
Selling ③	--	--
Sell ②	--	--
Selling ①	--	--
deal	--
Buy ①	--	--
Buy ②	--	--
Buy ③	--	--
Buy ④	--	--
Buy ⑤	--	--
Outer disc -- Inner disc --

In case of a key big order, the main force may**

Quickly use level2 to view details>

Pen by pen

Large order

Price sharing

Time-sharing

time	Price (yuan)	Measurement (hand)	nature

time	Price (yuan)	Measurement (hand)	nature

Transaction price (yuan)	Trading volume (hand)	Proportion (%)

time	Transaction price (yuan)	Trading volume (hand)

Scan code subscription

Investment research report

Questioning stocks

Live broadcast of stock market

Product entry: Sina Finance APP - Stocks - Investment Research Report

Product entrance: Sina Finance APP - stock - free question

money flow

Main compass Indicator description

Main and retail investors' capital flow
	Main buy	Main sales	Purchase by retail investors	Retail sales
Amount (10000 yuan)	@mainIn@	@mainOut@	@retailIn@	@retailOut@
proportion	@mainInP@	@mainOutP@	@retailInP@	@retailOutP@

Loose bill

Small order

Large order

Extra large order

Net inflow of classified funds
	Loose bill	Small order	Large order	Extra large order
Net inflow (10000 yuan)	@r3_r_in@	@r2_r_in@	@r1_r_in@	@r0_r_in@
Proportion in the flow board	@r3_p_svs@	@r2_p_svs@	@r1_p_svs@	@r0_p_svs@
Proportion in turnover rate	@r3_p_turnover@	@r2_p_turnover@	@r1_p_turnover@	@r0_p_turnover@

research report

Company research

Tianmu Pharmaceutical (600671): excellent corporate governance

Industry research

Big V view

ST target drug stock exchange

title click reply Final reply

[ST target drug: violation guarantee has been settled] ST target drug one hundred and eighty-five zero 06-14 19:52
[* ST target drug: cancel delisting risk warning and continue to implement one hundred and twenty-eight zero 06-12 20:05
[* ST target drug: report meeting for the first quarter of 2024 two hundred and forty zero 06-04 22:17
*ST target drugs rose 4.06% at the opening one hundred and twenty-six zero 06-03 09:26
[* ST target medicine: wholly-owned subsidiary Huangshan Tianmu Pharmaceutical Co., Ltd two hundred and forty-four zero 05-23 20:44
*ST target drugs fell 3.95% at the opening two hundred and thirty-three zero 05-14 09:26
*ST target drugs rose 3.06% at the opening one hundred and seventy-four zero 05-08 09:26
*ST target drugs fell 4.78% at the opening two hundred zero 05-06 09:27

*ST target drugs fell 3.15% at the opening three hundred and eighty-six zero 04-22 09:27
*ST target drugs fell 3.71% at the opening two hundred and seventy-three zero 04-19 09:26
Before the annual report, * ST target drugs must control their positions three hundred and thirty-five zero 04-18 21:47
*ST target drugs fell 4.31% at the opening two hundred and thirty zero 04-17 09:27
*ST target drugs fell 4.97% at the opening two hundred and thirty-two zero 04-15 09:26
*On March 18, ST target drug now has a large transaction transaction gold five hundred and twenty-four zero 03-18 17:40
[* ST target drug: Chairman Li Feng, General Manager Liu Bo resigns one thousand four hundred and eighty-seven one 03-17 10:54
*On March 15, ST target drug now has a large transaction transaction gold three hundred and fifty-four zero 03-15 17:40

Company research

Hot data

Adjacent ranking

Top 10 in the industry

Financial ratios

Adjacent ranking

Top 10 in the industry

Investment rating of research institutions

In the last 60 days The ST target drug (sh600671) rating was released in three research reports, and the comprehensive rating is as follows:

Hot columns

Industry comparison

name	Price (yuan)

expand all Pack All

Investment instruments

Market trend

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

corporate name:

Hangzhou Tianmushan Pharmaceutical Co., Ltd

Main business:

Pharmaceutical manufacturing, drug circulation, TCM diagnosis and treatment, etc

Telephone: 0571-63722229

Fax: 0571-63715400

Date of establishment: 1993-08-12

Listing date: 1993-08-23

Legal representative: Liu Jiayong

general manager: Xu Xuyu

Registered capital: 121779000 yuan

Issue price: 1 yuan

Latest total share capital: 121778885 shares

Latest outstanding shares: 121720533 shares

Segment: Shanghai and Shenzhen A-share Shanghai A-share Risk warning board of SSE Pharmaceuticals Pharmaceutical Biology Traditional Chinese Medicine II Pharmaceutical Biology Traditional Chinese Medicine III Small disk traditional Chinese medicine Healthy China ST plate

Financial summary

2024-03

2023-12

2023-09

2023-06

2023-03

Earnings per share	-0.0798 yuan	-0.3143 yuan	-0.2255 yuan	-0.1923 yuan	-0.0744 yuan
net asset value per share	0.2251 yuan	0.3050 yuan	-0.3456 yuan	-0.3124 yuan	-0.1945 yuan
Net operating cash flow per share	-0.0293 yuan	-0.1678 yuan	-0.2372 yuan	-RMB 0.2484	-0.0985 yuan
Return on net assets	-35.46%	-103.06%	0%	0%	0%
Undistributed profit per share	-2.3102 yuan	-2.2304 yuan	-2.1419 yuan	-2.1087 yuan	-1.9907 yuan
Capital reserve per share	1.3367 yuan	1.3367 yuan	RMB 0.5977	RMB 0.5977	RMB 0.5977

Date of announcement	Allocation scheme
2005-08-18	10 pies 1.8 yuan
2002-07-17	10 pairs 0.1 yuan
2001-06-30	10 pairs 0.2 yuan
1999-06-11	10 pairs1 yuan
1998-08-12	10 pairs1 yuan

Circulation shareholders

2024-03

2023-12

2023-09

Name of shareholders	Shareholding (%)	Increase or decrease
Qingdao Huilong Huaze Investment Co., Ltd	thirty point zero zero three	Unchanged
Qingdao Yuanjia Medical Department	twelve point three six one	Unchanged
Zhejiang breeze original text	four point two five seven	Unchanged
Hangzhou Yuedian Run Investment Co., Ltd	three point two eight six	Unchanged
Qingdao shared emergency safety	two point eight two three	Unchanged
Li Junfeng	two point two six five	Unchanged
Li Hongxin	one point seven nine two	Unchanged
Gai Liandong	one point seven five three	Unchanged
Gao Wenyuan	one point five six nine	Overweight
Li Jie	one point three one four	Unchanged

Name of shareholders	Shareholding (%)	Increase or decrease
Qingdao Huilong Huaze Investment Co., Ltd	thirty point zero zero three	Overweight
Qingdao Yuanjia Medical Department	twelve point three six one	New progress
Zhejiang breeze original text	four point two five seven	Unchanged
Hangzhou Yuedian Run Investment Co., Ltd	three point two eight six	Unchanged
Qingdao shared emergency safety	two point eight two three	Unchanged
Li Junfeng	two point two six five	Unchanged
Li Hongxin	one point seven nine two	Unchanged
Gai Liandong	one point seven five three	Unchanged
Gao Wenyuan	one point five six six	Overweight
Li Jie	one point three one four	Unchanged

Name of shareholders	Shareholding (%)	Increase or decrease
Qingdao Huilong Huaze Investment Co., Ltd	twenty-two point zero one seven	Unchanged
Yongxin Huarui Cultural Development Co., Ltd	twenty point three four seven	Unchanged
Zhejiang breeze original text	four point two five seven	Unchanged
Hangzhou Yuedian Run Investment Co., Ltd	three point two eight six	Unchanged
Qingdao shared emergency safety	two point eight two three	reduce one's shares in a listed company
Li Junfeng	two point two six five	Unchanged
Li Hongxin	one point seven nine two	Unchanged
Gai Liandong	one point seven five three	Unchanged
Gao Wenyuan	one point four five eight	reduce one's shares in a listed company
Li Jie	one point three one four	reduce one's shares in a listed company

user name:
Password:
	Record login status for one month
	Sign in Retrieve password Login Help Not yet a member of Sina? New User Registration

ST eye drug (600671.SH)

Investment research report

Live broadcast of stock market

money flow

Company Information

research report

Big V view

Company No

ST target drug stock exchange

Company research

Hot data

Financial ratios

Investment rating of research institutions

Hot columns

Industry comparison

Investment instruments

Market trend

Company information

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

Financial summary

Dividend distribution

Circulation shareholders

Shareholding ratio of circulating shareholders